Home Market News Roadblocks and Hurdles: Will Translarna Find Its Way to Approval?

Roadblocks and Hurdles: Will Translarna Find Its Way to Approval?

0
Roadblocks and Hurdles: Will Translarna Find Its Way to Approval?
Duchenne muscular dystrophy genetic test

Hailshadow

PTC Therapeutics, listed on NASDAQ as PTCT, recently faced a stormy journey in its quest for regulatory approvals for Translarna.